PlainRecalls
FDA Drug Low Class III Ongoing

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.

Reported: October 22, 2025 Initiated: October 9, 2025 #D-0024-2026

Product Description

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Details

Recalling Firm
STAQ Pharma, Inc.
Distribution
Nationwide in the U.S.
Location
Denver, CO

Frequently Asked Questions

What product was recalled?
Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.. Recalled by STAQ Pharma, Inc..
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date
Which agency issued this recall?
This recall was issued by the FDA Drug on October 22, 2025. Severity: Low. Recall number: D-0024-2026.